Inhibition of EZH2 in MM leads to the downregulation of a c-MYC signature, the upregulation of cell cycle control genes including the CDK inhibitors CDKN1A/p21 and CDKN2B/p15 leading to cell cycle arrest and apoptosis [1, 98]. Here, EZH2 is linked to Miyoshi myopathy.